Abstract: PO0986
Microscopic Hematuria Is a Risk Factor for ESKD in Patients with Biopsy-Proven Diabetic Nephropathy
Session Information
- Diabetic Kidney Disease: Clinical - 1
October 22, 2020 | Location: On-Demand
Abstract Time: 10:00 AM - 12:00 PM
Category: Diabetic Kidney Disease
- 602 Diabetic Kidney Disease: Clinical
Authors
- Furuyama, Riri, Nara Medical University, Kashihara, Nara, Japan
- Eriguchi, Masahiro, Nara Medical University, Kashihara, Nara, Japan
- Tasaki, Hikari, Nara Medical University, Kashihara, Nara, Japan
- Fukata, Fumihiro, Nara Medical University, Kashihara, Nara, Japan
- Nishimoto, Masatoshi, Nara Medical University, Kashihara, Nara, Japan
- Kosugi, Takaaki, Nara Medical University, Kashihara, Nara, Japan
- Tanabe, Kaori, Nara Medical University, Kashihara, Nara, Japan
- Morimoto, Katsuhiko, Nara Prefecture Western Medical Center, Ikoma, Japan
- Okada, Sadanori, Nara Medical University, Kashihara, Nara, Japan
- Matsui, Masaru, Nara Prefecture General Medical Center, Nara, Japan
- Samejima, Ken-ichi, Nara Medical University, Kashihara, Nara, Japan
- Tsuruya, Kazuhiko, Nara Medical University, Kashihara, Nara, Japan
Background
Microscopic hematuria is rarely observed in patients with diabetic nephropathy (DN). Some studies have reported that hematuria is a risk factor for end-stage kidney disease (ESKD) in glomerulonephritis, but association of hematuria with renal prognosis in DN is unknown.
Methods
The present study is a retrospective cohort study of patients with DN confirmed by renal biopsy between June 1981 and December 2014. The participants were followed until October 2018 or death. Exposure of interest is the presence of hematuria (U-RBC >5) and main outcome was the occurrence of ESKD. The association of hematuria with ESKD was evaluated using Cox hazard model with adjustment for clinically relevant factors [age, sex, eGFR, proteinuria, body mass index, systolic blood pressure (SBP) and pathological evaluations].
Results
Patients who had microscopic hematuria at the time of renal biopsy were defined as the hematuria group (N = 91), and the remainder as the non-hematuria group (N = 306). Hematuria group had more proportion of male, higher SBP, more proteinuria, and lower eGFR compared with non-hematuria group. Pathological findings revealed that glomerular, tubulointerstitial, and vascular lesions in the hematuria group were significantly more severe than those in non-hematuria group. During a median follow-up period of 80 months, 44 and 52 patients developed ESKD in the hematuria group and non-hematuria groups, respectively. Survival analyses showed that incidence of ESKD was significantly higher in the hematuria group (P <0.0001). The significance remained robust even after adjustment for confounding factors (adjusted HR 1.64, 95% CI; 1.03-2.60). In the subgroup analyses, the associations of hematuria with ESKD among male and overt proteinuria (≥0.5 g/day) were stronger than those among female and micro proteinuria (<0.5 g/day), respectively (P values for interaction <0.1 and <0.03, respectively).
Conclusion
The presence of microscopic hematuria is an independent risk factor for ESKD in diabetic nephropathy.